Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion type Assertion NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_head.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion description "[Two recent clinical trials have shown that the placenta growth factor (PlGF) is up-regulated after bevacizumab treatment in colorectal cancer and after SU11248 treatment in metastatic renal cell carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_provenance.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion evidence source_evidence_literature NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_provenance.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion SIO_000772 17704140 NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_provenance.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion wasDerivedFrom befree-20150227 NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_provenance.
- NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_assertion wasGeneratedBy ECO_0000203 NP617110.RAn2O6kLanWxeO9a8klc0MrTUK-hRthA3La3MlBft71mE130_provenance.